SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,705 | +37.4% | 517,286 | +29.8% | 0.04% | +34.5% |
| Q2 2023 | $45,639 | -27.0% | 398,525 | -12.1% | 0.03% | 0.0% |
| Q1 2023 | $62,521 | +16.3% | 453,610 | +9.3% | 0.03% | +20.8% |
| Q4 2022 | $53,778 | -99.8% | 415,008 | +49.0% | 0.02% | -29.4% |
| Q3 2022 | $30,782,000 | +95.6% | 278,466 | +32.6% | 0.03% | +240.0% |
| Q2 2022 | $15,739,000 | +284.0% | 209,970 | +300.2% | 0.01% | +233.3% |
| Q1 2022 | $4,099,000 | -63.3% | 52,472 | -57.7% | 0.00% | +50.0% |
| Q4 2021 | $11,172,000 | +98.1% | 124,126 | +103.6% | 0.00% | 0.0% |
| Q3 2021 | $5,639,000 | +294.1% | 60,980 | +231.5% | 0.00% | +100.0% |
| Q2 2021 | $1,431,000 | -64.4% | 18,394 | -65.9% | 0.00% | -50.0% |
| Q1 2021 | $4,015,000 | -71.1% | 53,886 | -33.9% | 0.00% | -75.0% |
| Q4 2020 | $13,888,000 | +9.9% | 81,463 | -9.5% | 0.01% | 0.0% |
| Q3 2020 | $12,636,000 | -30.9% | 89,985 | -21.1% | 0.01% | -42.9% |
| Q2 2020 | $18,294,000 | -51.3% | 114,091 | -70.3% | 0.01% | -51.7% |
| Q1 2020 | $37,532,000 | -40.9% | 383,689 | -22.1% | 0.03% | -17.1% |
| Q4 2019 | $63,536,000 | +160.8% | 492,380 | +52.2% | 0.04% | +150.0% |
| Q3 2019 | $24,364,000 | -66.1% | 323,481 | -31.6% | 0.01% | -68.2% |
| Q2 2019 | $71,860,000 | +83.7% | 472,922 | +44.1% | 0.04% | +63.0% |
| Q1 2019 | $39,126,000 | +86.1% | 328,271 | +70.4% | 0.03% | +58.8% |
| Q4 2018 | $21,028,000 | -31.1% | 192,684 | +1.9% | 0.02% | -19.0% |
| Q3 2018 | $30,526,000 | -50.2% | 189,000 | -59.2% | 0.02% | -60.4% |
| Q2 2018 | $61,252,000 | +308.2% | 463,409 | +128.8% | 0.05% | +341.7% |
| Q1 2018 | $15,005,000 | -50.9% | 202,539 | -63.1% | 0.01% | -52.0% |
| Q4 2017 | $30,564,000 | +6.5% | 549,302 | -13.2% | 0.02% | -16.7% |
| Q3 2017 | $28,696,000 | +303.9% | 632,642 | +200.2% | 0.03% | +328.6% |
| Q2 2017 | $7,104,000 | +25.2% | 210,729 | +10.0% | 0.01% | 0.0% |
| Q1 2017 | $5,673,000 | -78.1% | 191,619 | -79.7% | 0.01% | -75.0% |
| Q4 2016 | $25,871,000 | -77.3% | 943,210 | -49.3% | 0.03% | -77.8% |
| Q3 2016 | $114,179,000 | +476.8% | 1,859,318 | +79.1% | 0.13% | +404.0% |
| Q2 2016 | $19,794,000 | +11969.5% | 1,038,010 | +11901.5% | 0.02% | – |
| Q1 2016 | $164,000 | -98.7% | 8,649 | -97.3% | 0.00% | -100.0% |
| Q4 2015 | $12,223,000 | +19.3% | 321,651 | +0.4% | 0.02% | +25.0% |
| Q3 2015 | $10,249,000 | +288.7% | 320,244 | +264.5% | 0.01% | +300.0% |
| Q2 2015 | $2,637,000 | +9317.9% | 87,869 | +3977.4% | 0.00% | – |
| Q1 2015 | $28,000 | -90.4% | 2,155 | -89.6% | 0.00% | – |
| Q4 2014 | $291,000 | -37.3% | 20,817 | -5.8% | 0.00% | – |
| Q3 2014 | $464,000 | -30.4% | 22,105 | -3.9% | 0.00% | -100.0% |
| Q2 2014 | $667,000 | -67.3% | 23,000 | -73.0% | 0.00% | -50.0% |
| Q1 2014 | $2,041,000 | -85.0% | 85,043 | -87.5% | 0.00% | -85.7% |
| Q4 2013 | $13,574,000 | -72.6% | 678,703 | -35.5% | 0.01% | -76.3% |
| Q3 2013 | $49,465,000 | -52.9% | 1,052,462 | -61.8% | 0.06% | -54.6% |
| Q2 2013 | $104,936,000 | – | 2,758,616 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |